All hubs

Fundraising

Negotiating term sheets — the operator's playbook

A term sheet is a 3-5 page document that decides the next 7-10 years of a company. Most founders read it once, ask their lawyer to translate the scary bits, and sign. That's how founders end up owning 8% of a $200M outcome instead of 18%. This hub walks through the terms that matter, what's market vs aggressive, and where the actual negotiation leverage lives. It's not a substitute for a startup lawyer — but it'll make every conversation with one shorter and sharper.

Last updated June 8, 2026

Who this is for

Founders with a term sheet (or about to have one) who want to understand which terms matter, which are theatre, and where the leverage actually lives.

What you'll learn

  • Reading a term sheet term-by-term — and which terms compound the most
  • Standard vs aggressive — what's normal at seed, Series A, and beyond
  • What to fight for vs what to concede — the trade-offs that matter
  • Negotiation leverage — what gives you it, what kills it
  • When to walk away (and how to do it without burning the relationship)
Model your dilution scenarios

The terms that actually compound

Not all terms matter equally. These are the ones where a 'bad' answer compounds the most across future rounds:

1. Valuation (pre-money / post-money). Obvious one. But pre-money valuation × dilution is what determines founder ownership, not the headline number. A $20M pre-money with a 20% post-money option pool top-up dilutes founders the same as a $16M pre-money with no top-up.

2. Option pool top-up. The investor wants the option pool (usually 10-15% post-money) to come from pre-money — diluting existing holders (founders) but not the new investor. This is often negotiable. Push for a smaller pool based on a real hiring plan, or for the pool to be diluted across both pre- and post-money.

3. Liquidation preference. 1x non-participating is standard. 1x participating or >1x preferences flip the economics of small/medium exits and can leave founders with $0 on a $30M sale.

4. Anti-dilution. Weighted-average is standard. Full-ratchet is aggressive and rarely justified — push back hard.

5. Board composition. At seed: 1 founder seat, 1 investor seat, 1 mutually-agreed independent. Anything that gives investors a board majority pre-Series A is aggressive.

6. Protective provisions. Investor consent for: sale of the company, new share class, debt above threshold, change of business model. Standard set is reasonable; expanded sets (consent for hiring senior execs, opening new offices, etc.) are over-reach.

Terms that don't move the needle much: drag-along, tag-along, ROFR, information rights, pro-rata. These have market norms; deviate only if you have specific reason.

What's market vs what's aggressive

Pre-seed / seed (typically SAFE or convertible note, sometimes priced):

  • Valuation cap: $5-15M for pre-seed, $10-25M for seed
  • Discount: 15-20% (if convertible note)
  • Liquidation preference: 1x non-participating (when priced)
  • Option pool: 10-12% post-money (if forced; otherwise leave for Series A)
  • Board: founder-controlled (no investor board seat at this stage usually)

Series A:

  • Valuation: market-driven; ARR multiples in the 30-80x range as of 2026
  • Liquidation preference: 1x non-participating, standard
  • Option pool: 10-15% post-money top-up (this is where the negotiation happens)
  • Board: 1 founder, 1 investor (lead), 1 independent (mutually selected)
  • Protective provisions: standard ~10-item list, no aggressive expansions
  • Pro-rata: standard for the lead, sometimes for follow-on investors above a minimum

Aggressive (push back hard):

  • 2x+ liquidation preference (especially participating)
  • Full-ratchet anti-dilution
  • Investor board control at seed or Series A
  • Investor consent for hiring executives or routine operating decisions
  • Lock-up provisions on founder shares beyond standard vesting

Walk-away terms (rare but real):

  • 3x+ participating preference
  • Founder vesting reset (pre-existing vested founder shares becoming subject to re-vest)
  • Investor consent for any sale of the company at any price
  • Removal of founder protection in the event of involuntary termination

Negotiation leverage and how to use it

What gives you leverage:

  • Multiple term sheets (or a credible "we're talking to others")
  • Strong metrics relative to your stage (ARR growth, NRR, payback period)
  • A genuine BATNA — bootstrapping or alternative paths to next-round metrics
  • Reputational reach (the investor needs you more than they're letting on)
  • Time (founders who can wait 4-6 weeks for terms get better terms than founders raising on 2-week runway)

What kills leverage:

  • Telling the investor your runway months ("we have 4 months left" = brutal terms)
  • Telling the investor you've been turned down by others
  • Showing up unprepared on the terms — investors push harder when they sense the founder doesn't understand what's being discussed
  • Negotiating each term independently rather than as a package

Negotiation tactics that work:

  • Open with a written request listing the 3-5 specific changes you want, not a phone call
  • Tie concessions: "we'll accept your liquidation preference if you drop the participating clause"
  • Use the lawyer as the bad cop — "my lawyer says…" gives you cover to push on hard terms
  • Match the level of formality the investor uses — over-formality on the founder side reads as inexperience

When to walk away:

  • The investor refuses to move on a deal-breaker term (anti-dilution full-ratchet, founder vesting reset, etc.)
  • The investor is consistently slow to respond — predicts the entire relationship
  • You're being pushed to close in <2 weeks without time for legal review — almost always means there's a term they don't want you to think about

Walking away is a tactic, not a failure. The investor who's serious will come back with better terms. The investor who doesn't come back wasn't the right partner.

Step-by-step action plan

Do these, in order

  1. 1Engage a startup lawyer before signing any term sheet — even a SAFE
  2. 2List your top 3 deal-breakers and top 3 negotiable items before the call
  3. 3Negotiate the package, not the individual terms
  4. 4Never accept a closing timeline shorter than 6 weeks from term sheet to wire
  5. 5If the relationship feels wrong on day one, the relationship will be wrong on day 1,000 — walk

Frequently asked questions

Do I need a lawyer for a SAFE / pre-seed term sheet?
Yes, even for a SAFE. A startup-specialist lawyer (Cooley, Goodwin, Orrick, or boutique alternative) reviews the cap, discount, and any side letters for ~$2,000-5,000. Worth every penny.
How long should the negotiation take?
Term sheet itself: 1-3 weeks. Definitive docs after signed term sheet: 3-6 weeks. Investors who push for shorter timelines are usually trying to limit your due-diligence window. Don't be rushed.
Should I share competing term sheets with investors?
You can mention you have one (improves leverage). Don't share the actual document — partly to preserve trust with the other investor, partly to keep your negotiating leverage. 'We have a competing term sheet and the headline is similar' is enough.
What if my lead drops out mid-negotiation?
Common, especially in tighter markets. Don't try to rush a replacement — investors smell desperation. Either accept the next-best term sheet, or extend runway and come back to market in 6 months with better metrics.

Related resources

Related tools

Related templates

Related courses

Related hubs